quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:15·1911d
SECFiling
Eidos Therapeutics, Inc. logo

SEC Form EFFECT filed

EIDX· Eidos Therapeutics, Inc.
Health Care
Original source

Companies

  • EIDX
    Eidos Therapeutics, Inc.
    Health Care

Related

  • PR1760d
    BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer
  • PR1883d
    BridgeBio Pharma, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results And Business Update
  • SEC1903d
    SEC Form 15-12B filed
  • INSIDER1911d
    SEC Form 4: C Jonathan Fox gifted 500 units of Common Stock, decreasing ownership by 100% to 0 units
  • INSIDER1911d
    SEC Form 4 filed by Douglas Rohlen
  • INSIDER1911d
    SEC Form 4 filed by Franco Valle
  • INSIDER1911d
    SEC Form 4: Cameron Turtle decreased ownership by 100% to 0 units
  • INSIDER1911d
    SEC Form 4 filed by J. Ali Satvat
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022